Market

BAL PHARMA LTD.

  • NSE CodeBALPHARMAEQ
  • BSE Code524824
  • ISININE083D01012
  • IndustryPharmaceuticals


Company Information

Management

Mr. Abdul Basith

Co. Secretary & Compl. Officer

Mr. D V Bharath Bhushan

Chief Financial Officer

Incorporation Year

19/05/1987

Registered Address


Bengaluru, Karnataka - 560099
Tel: 080-22354057
Fax: 080-41570820

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@balpharma.com

Website

http://www.balpharma.com

Listing

BSE, MCXSX, NSE

Corporate News

Bal Pharma - Dividend

27-May-2026|7:06PM

Bal Pharma Limited has informed the Exchange that Board of Directors at its

Bal Pharma - Outcome of Board Meeting

27-May-2026|7:01PM

Bal Pharma Limited has submitted to the Exchange, the financial results for

Bal Pharma - Outcome of Board Meeting

27-May-2026|6:50PM

Bal Pharma Limited has submitted to the Exchange, the financial results for

Bal Pharma - Audited Financial Results-Standalone & C...

27-May-2026|6:43PM

Audited financial results of the company for the quarter and financial year

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug77.99221.14
Aarti Drug380.403,471.91
Aarti Pharma633.255,740.90
Abbott India26,855.0057,065.00
Accent Micro441.951,060.19

MF Holding

No Data Available

Board Meetings

DatePurpose
27/05/2026Audited Results, Final ..
11/02/2026Quarterly Results
12/11/2025Quarterly Results
11/08/2025Quarterly Results, ESOP..
29/05/2025Audited Results & D..
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.